Bevacizumab Shows Activity in Rare Ovarian CancerBevacizumab Shows Activity in Rare Ovarian Cancer
Dr. Rachel Grisham describes favorable responses to bevacizumab treatment in recurrent and persistent low-grade serous and serous borderline ovarian cancer. Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
More News: Avastin | Borderline Serous Tumor | Cancer | Cancer & Oncology | Health | Hematology | Ovarian Cancer | Ovaries